[Activity Report] Himeji City becomes first municipality in Japan to issue declaration on the promotion of AMR countermeasures (February 21, 2022)
date : 4/25/2022
Tags: AMR
![[Activity Report] Himeji City becomes first municipality in Japan to issue declaration on the promotion of AMR countermeasures (February 21, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-32-top.jpg)
In February 2022, AMR Alliance Japan member Himeji City released its “Declaration of Himeji City as a City Promoting Countermeasures against AMR.”
During his first policy speech of FY2022, Mayor Kiyomoto Hideyasu said, “We must raise the alarm about antimicrobial resistance, which spreads through the improper use of antimicrobials and could cause infectious diseases to become untreatable. I declare Himeji City a ‘City Promoting Countermeasures against AMR.’ We will work to spread the word about this problem among our citizens and medical professionals.”
The new declaration was created following a symposium hosted by AMR Alliance Japan, “WHO Regional Committee for the Western Pacific Related Event: ‘AMR: A Global Health Crisis.’” A report on that symposium can be found here.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
![[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_3rd_nominations_eyecatch_caseB_ENG_web_20260929_v0.5.jpg)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
![[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261001_Eyecatch_HGPIseminer-146th-1.png)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
![[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261016_Policy-Column-2-Blood-Disorders.png)
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)
![[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/PolicyRecommendations_IntractableAndRareDiseas.jpg)
